Page 93 - OR-1-3
P. 93

phenotype in a cartilage-on-a-chip model. Nat Biomed Eng.   209. Marcacci M, Kon E, Zaffagnini S,  et  al. Reconstruction
                2019;3:545-557.                                  of extensive long-bone defects in sheep using porous
                                                                 hydroxyapatite sponges. Calcif Tissue Int. 1998;64:83-90.
                doi: 10.1038/s41551-019-0406-3
                                                                 doi: 10.1007/s002239900583
            198. Lin X, Lin T, Wang X,  et al. Sesamol serves as a p53
                stabilizer  to  relieve  rheumatoid  arthritis  progression  and   210. Mikael PE, Golebiowska AA, Kumbar SG, Nukavarapu SP.
                inhibits the growth of synovial organoids.  Phytomedicine.   Evaluation of  autologously  derived  biomaterials  and
                2023;121:155109.                                 stem cells for bone tissue engineering.  Tissue Eng Part  A.
                                                                 2020;19:1052-1063.
                doi: 10.1016/j.phymed.2023.155109
                                                                 doi: 10.1089/ten.TEA.2020.0011
            199. Wang X, He J, Zhang Q, He J, Wang Q. Constructing a 3D
                co-culture  in vitro synovial tissue model for rheumatoid   211. Vainieri ML, Wahl D, Alini M, van Osch GJVM, Grad S.
                arthritis research. Mater Today Bio. 2025;31:101492.  Mechanically stimulated  osteochondral organ culture for
                                                                 evaluation of biomaterials in cartilage repair studies.  Acta
                doi: 10.1016/j.mtbio.2025.101492
                                                                 Biomater. 2018;81:256-266.
            200. Nie JH, Yang T, Li H, et al. Frequently expressed glypican‐3
                as a promising novel therapeutic target for osteosarcomas.      doi: 10.1016/j.actbio.2018.09.058
                Cancer Sci. 2022;113:3618-3632.               212. Chen W, Liu D, Lu K, et al. Organoids of musculoskeletal
                                                                 system for disease modeling, drug screening, and
                doi: 10.1111/cas.15521
                                                                 regeneration. Adv Healthc Mater. 2025;14:e2402444.
            201. Suzuki  R,  Wakamatsu  T,  Yoshida  K,  et al.  Genetic
                characterization of a novel organoid from human malignant      doi: 10.1002/adhm.202402444
                giant-cell tumor. J Bone Oncol. 2023;41:100486.  213. Rossi G, Manfrin A, Lutolf MP. Progress and potential in
                                                                 organoid research. Nat Rev Genet. 2018;19:671-687.
                doi: 10.1016/j.jbo.2023.100486
                                                                 doi: 10.1038/s41576-018-0051-9
            202.  Forsythe SD, Sivakumar H, Erali RA,  et al. Patient-specific
                sarcoma organoids for personalized translational research:   214. Hu Y, Zhang H, Wang S,  et al. Bone/cartilage organoid
                Unification of the operating room with rare cancer research   on-chip: Construction strategy and application.  Bioact
                and clinical implications. Ann Surg Oncol. 2022;29:7354-7367.  Mater. 2023;25:29-41.
                doi: 10.1245/s10434-022-12086-y                  doi: 10.1016/j.bioactmat.2023.01.016
            203. Parvatam S, Pistollato F, Marshall LJ,  et al. Human-based   215. Editorial. An update on organoid research.  Nat Cell Biol.
                complex in vitro models: Their promise and potential for rare   2018;20:633.
                disease therapeutics. Front Cell Dev Biol. 2025;13:1526306.
                                                                 doi: 10.1038/s41556-018-0119-y
                doi: 10.3389/fcell.2025.1526306
                                                              216. Wan  A.  Recapitulating  cell-cell  interactions  for  organoid
            204. Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug   construction  -  are biomaterials dispensable?  Trends
                development fails and how to improve it? Acta Pharm Sin B.   Biotechnol. 2016;34:711-721.
                2022;12:3049-3062.
                                                                 doi: 10.1016/j.tibtech.2016.02.015
                doi: 10.1016/j.apsb.2022.02.002
                                                              217. Holloway EM, Capeling MM, Spence JR. Biologically
            205. Orloff J, Douglas F, Pinheiro J,  et al. The future of drug   inspired approaches to enhance human organoid complexity.
                development: Advancing clinical trial design. Nat Rev Drug   Development. 2019;146:dev166173.
                Discov. 2009;8:949-957.
                                                                 doi: 10.1242/dev.166173
                doi: 10.1038/nrd3025
                                                              218. Gao Q, Wang J, Zhang H, Wang J, Jing Y, Su J. Organoid
            206. Sedgwick P. What are the four phases of clinical research   vascularization: Strategies and applications.  Adv Healthc
                trials? BMJ. 2014;348:3727.                      Mater. 2025;14:e2500301.
                doi: 10.1136/bmj.g3727                           doi: 10.1002/adhm.202500301
            207. Chen S, Liu D, Guo Q,  et al. Facile construction of   219. Shin Y, Safina D, Zheng Y, Levenberg S. Microvascularization
                mechanically robust and highly osteogenic materials for   in 3D human engineered tissue and organoids.  Annu Rev
                bone regeneration. Mater Today Bio. 2025;32:101809.  Biomed Eng. 2025;27:473-498.
                doi: 10.1016/j.mtbio.2025.101809                 doi: 10.1146/annurev-bioeng-103023-115236
            208. Sharma B, Fermanian S, Gibson M, et al. Human cartilage   220. Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle
                repair with a photoreactive adhesive-hydrogel composite. Sci   metabolism is a major determinant of resting energy
                Transl Med. 2013;5:167ra166.                     expenditure. J Clin Invest. 1990;86:1423-1427.
                doi: 10.1126/scitranslmed.3004838                doi: 10.1172/jci114857


            Volume 1 Issue 3 (2025)                         35                           doi: 10.36922/OR025280024
   88   89   90   91   92   93   94   95   96   97   98